AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency
|
0.700 |
Biomarker
|
disease |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
AICAR Transformylase Inosine Monophosphate Cyclohydrolase Deficiency
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Rheumatoid Arthritis
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.
|
26799664 |
2016 |
Rheumatoid Arthritis
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
The results of the study suggest that ATIC missense rs2372536 SNP may influence response to MTX therapy in rheumatoid arthritis patients.
|
27885916 |
2016 |
Rheumatoid Arthritis
|
0.340 |
GeneticVariation
|
disease |
BEFREE |
MTHFR, DHFR and ATIC genetic variants can be considered as pharmacogenetic markers of outcome in RA patients under MTX monotherapy.
|
25084201 |
2014 |
Rheumatoid Arthritis
|
0.340 |
Biomarker
|
disease |
CTD_human |
Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate.
|
19193698 |
2009 |
Rheumatoid Arthritis
|
0.340 |
GeneticVariation
|
disease |
LHGDN |
Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis.
|
15457444 |
2004 |
Intellectual Disability
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Osteoporosis, Age-Related
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Osteoporosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Osteoporosis, Senile
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Post-Traumatic Osteoporosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Proteomic analysis of circulating monocytes in Chinese premenopausal females with extremely discordant bone mineral density.
|
18924182 |
2008 |
Drug toxicity
|
0.300 |
Biomarker
|
group |
CTD_human |
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
|
16947783 |
2006 |
Adverse reaction to drug
|
0.300 |
Biomarker
|
group |
CTD_human |
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis.
|
16947783 |
2006 |
Blindness, Transient
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Blindness, Hysterical
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Blindness, Legal
|
0.300 |
Biomarker
|
disease |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Blindness, Acquired
|
0.300 |
Biomarker
|
disease |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Amaurosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Blindness
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Blindness, Monocular
|
0.300 |
Biomarker
|
disease |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |
Blindness both eyes NOS (disorder)
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
AICA-ribosiduria: a novel, neurologically devastating inborn error of purine biosynthesis caused by mutation of ATIC.
|
15114530 |
2004 |